Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease [Phase 3]

View source ↗

Summary

This clinical trial update indicates that a Phase 3 study evaluating a polypill together with colchicine for reducing risk of atherosclerotic cardiovascular dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)
  • Polypill

Snippet

Sponsor: Hospital do Coracao | Conditions: Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD) | Phase 3 | Status: RECRUITING